Evidence map›Paper›PMID 38136725›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Activity of Cinnamic Acid Derivatives with 4-Chloro-2-mercaptobenzenesulfonamide Moiety against Clinical HLAR and VRE

Rafał Hałasa, Anita Bułakowska, Jarosław Sławiński, Magdalena Smoktunowicz, Aleksandra Rapacka-Zdończyk, Urszula Mizerska

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rafał HałasaDepartment of Pharmaceutical Microbiology, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.ORCID 0000-0001-8597-3917
Anita BułakowskaDepartment of Organic Chemistry, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.
Jarosław SławińskiDepartment of Organic Chemistry, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.ORCID 0000-0003-2794-5031
Magdalena SmoktunowiczDepartment of Pharmaceutical Microbiology, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.
Aleksandra Rapacka-ZdończykDepartment of Pharmaceutical Microbiology, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.ORCID 0000-0002-7611-0359
Urszula MizerskaCentre of Molecular and Macromolecular Studies, Department of Polymeric Nano-Materials, Polish Academy of Sciences, ul. Sienkiewicza 112, 90-363 Lodz, Poland.ORCID 0000-0003-3507-5486
Gdańsk Medical University · PLCentrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid increase in strains that are resistant to antibiotics requires new active compounds to be found whose mechanism of action on bacteria is different to those that are currently known. Of particular interest are compounds that occur in plants as secondary metabolites. The focus of this study concerns the examination of the effects of synthetic cinnamic acid derivatives, with 4-chloro-2-mercaptobenzenesulfonamide moiety on

Indexed as

2-mercaptobenzenesulfonamideantibiofilmcheckerboard assaycinnamic acid derivativesEnterococcus spp.synergism

Identifiers

PMID38136725
PMCPMC10741072
OpenAlexW4389274541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.